Cargando…

Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study

Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent studies have proposed the use of antimicrobial combination therapy composed of a beta-lactam with either ciprofloxacin or tobramycin. To determine if combination therapy correlates to lower mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulsson, M., Granrot, A., Ahl, J., Tham, J., Resman, F., Riesbeck, K., Månsson, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495847/
https://www.ncbi.nlm.nih.gov/pubmed/28110415
http://dx.doi.org/10.1007/s10096-017-2907-x
_version_ 1783247863611916288
author Paulsson, M.
Granrot, A.
Ahl, J.
Tham, J.
Resman, F.
Riesbeck, K.
Månsson, F.
author_facet Paulsson, M.
Granrot, A.
Ahl, J.
Tham, J.
Resman, F.
Riesbeck, K.
Månsson, F.
author_sort Paulsson, M.
collection PubMed
description Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent studies have proposed the use of antimicrobial combination therapy composed of a beta-lactam with either ciprofloxacin or tobramycin. To determine if combination therapy correlates to lower mortality and is superior compared to monotherapy, we investigated the effect of antimicrobial treatment regimens on 30-day mortality in a cohort with Pseudomonas aeruginosa bacteraemia. All cases of P. aeruginosa bacteraemia (n = 292) in southwest Skåne County, Sweden (years 2005–2010, adult population 361,112) and the whole county (2011–2012, 966,130) were identified. Available medical and microbiological records for persons aged 18 years or more were reviewed (n = 235). Antimicrobial therapy was defined as empiric at admission or definitive after culture results and was correlated to 30-day mortality in a multivariate regression model. The incidence and mortality rates were 8.0 per 100,000 adults and 22.9% (67/292), respectively. As expected, multiple comorbidities and high age were associated with mortality. Adequate empiric or definitive antipseudomonal treatment was associated with lower mortality than other antimicrobial alternatives (empiric p = 0.02, adj. p = 0.03; definitive p < 0.001, adj. p = 0.007). No difference in mortality was seen between empiric antipseudomonal monotherapy or empiric combination therapy. However, definitive combination therapy including ciprofloxacin correlated to lower mortality than monotherapy (p = 0.006, adj. p = 0.003), whereas combinations including tobramycin did not. Our results underline the importance of adequate antipseudomonal treatment. These data also suggest that P. aeruginosa bacteraemia should be treated with an antimicrobial combination including ciprofloxacin when susceptible. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10096-017-2907-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5495847
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54958472017-07-18 Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study Paulsson, M. Granrot, A. Ahl, J. Tham, J. Resman, F. Riesbeck, K. Månsson, F. Eur J Clin Microbiol Infect Dis Original Article Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent studies have proposed the use of antimicrobial combination therapy composed of a beta-lactam with either ciprofloxacin or tobramycin. To determine if combination therapy correlates to lower mortality and is superior compared to monotherapy, we investigated the effect of antimicrobial treatment regimens on 30-day mortality in a cohort with Pseudomonas aeruginosa bacteraemia. All cases of P. aeruginosa bacteraemia (n = 292) in southwest Skåne County, Sweden (years 2005–2010, adult population 361,112) and the whole county (2011–2012, 966,130) were identified. Available medical and microbiological records for persons aged 18 years or more were reviewed (n = 235). Antimicrobial therapy was defined as empiric at admission or definitive after culture results and was correlated to 30-day mortality in a multivariate regression model. The incidence and mortality rates were 8.0 per 100,000 adults and 22.9% (67/292), respectively. As expected, multiple comorbidities and high age were associated with mortality. Adequate empiric or definitive antipseudomonal treatment was associated with lower mortality than other antimicrobial alternatives (empiric p = 0.02, adj. p = 0.03; definitive p < 0.001, adj. p = 0.007). No difference in mortality was seen between empiric antipseudomonal monotherapy or empiric combination therapy. However, definitive combination therapy including ciprofloxacin correlated to lower mortality than monotherapy (p = 0.006, adj. p = 0.003), whereas combinations including tobramycin did not. Our results underline the importance of adequate antipseudomonal treatment. These data also suggest that P. aeruginosa bacteraemia should be treated with an antimicrobial combination including ciprofloxacin when susceptible. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10096-017-2907-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-01-21 2017 /pmc/articles/PMC5495847/ /pubmed/28110415 http://dx.doi.org/10.1007/s10096-017-2907-x Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Paulsson, M.
Granrot, A.
Ahl, J.
Tham, J.
Resman, F.
Riesbeck, K.
Månsson, F.
Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study
title Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study
title_full Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study
title_fullStr Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study
title_full_unstemmed Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study
title_short Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study
title_sort antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of pseudomonas aeruginosa bacteraemia: a retrospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495847/
https://www.ncbi.nlm.nih.gov/pubmed/28110415
http://dx.doi.org/10.1007/s10096-017-2907-x
work_keys_str_mv AT paulssonm antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy
AT granrota antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy
AT ahlj antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy
AT thamj antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy
AT resmanf antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy
AT riesbeckk antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy
AT manssonf antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy